TP53 and breast cancer: Furthermore, coimmunoprecipitation experiment showed p53 was detected in the anti-Bmi1 immunoprecipitation complex (Figure 4G), implying Bmi1 maybe mediate p53 downregulation in wild-type p53 breast cancer cells to inhibit miR-200c expression.